IRVINE, Calif.--(BUSINESS WIRE)--BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for its full year and fourth quarter ended December 31, 2016.
2016 Full Year highlights with comparisons to 2015 Full Year include:
Worldwide revenue of $51.8 million, an increase of $3.3 million, or 7%, driven by U.S. sales
Worldwide Waterlase® revenue increased 8%, driven by a 15% increase in the U.S.
Worldwide EPIC® revenue increased 8%, driven by a 21% increase in U.S. sales
Worldwide imaging revenue increased $829,000, or 37%
